Jiali Wang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Glycemic Control

Replacement Therapy

Top Venues

EMBO molecular medicine

Cancer management and research

Alzheimer's research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Jiali Wang, Yaping Wang, Yong Xu, Wenfeng Fu, Liucheng Rong, Yao Xue, Yongjun Fang
Aligning the Cord Blood-Bone Marrow Differences and the Post-transplantation Clinical Manifestations by Single-Cell RNA-Seq. Cell transplantation 32 (2023)
Jiali Wang, Yixuan Zhang, Xiaoquan Liu, Haochen Liu
Optimizing Adaptive Therapy Based on the Reachability to Tumor Resistant Subpopulation. Cancers 13 (21) (2021)
Jiali Wang, Yixuan Zhang, Xiaoquan Liu, Haochen Liu
Is the Fixed Periodic Treatment Effective for the Tumor System without Complete Information? Cancer management and research 13 (2021)
Yixuan Zhang, Jiali Wang, Xiaoquan Liu, Haochen Liu
Exploring the role of RALYL in Alzheimer's disease reserve by network-based approaches. Alzheimer's research & therapy 12 (1) (2020)